IN2015DN03826A - - Google Patents
Info
- Publication number
- IN2015DN03826A IN2015DN03826A IN3826DEN2015A IN2015DN03826A IN 2015DN03826 A IN2015DN03826 A IN 2015DN03826A IN 3826DEN2015 A IN3826DEN2015 A IN 3826DEN2015A IN 2015DN03826 A IN2015DN03826 A IN 2015DN03826A
- Authority
- IN
- India
- Prior art keywords
- subject
- pharmaceutical composition
- concentration
- dose
- time point
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261717609P | 2012-10-23 | 2012-10-23 | |
| PCT/US2013/066238 WO2014066428A1 (en) | 2012-10-23 | 2013-10-22 | Drug monitoring and regulation systems and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN03826A true IN2015DN03826A (enrdf_load_stackoverflow) | 2015-10-02 |
Family
ID=50486139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3826DEN2015 IN2015DN03826A (enrdf_load_stackoverflow) | 2012-10-23 | 2013-10-22 |
Country Status (9)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014055978A1 (en) | 2012-10-05 | 2014-04-10 | Baysient LLC | System and method for providing patient-specific dosing as a function of mathematical models |
| US11183287B2 (en) * | 2013-06-13 | 2021-11-23 | Carefusion 303, Inc. | Analytics regarding patient care |
| US10777313B2 (en) | 2013-06-13 | 2020-09-15 | Carefusion 303, Inc. | Analytics regarding ventilated patients |
| US12027243B2 (en) | 2017-02-17 | 2024-07-02 | Hc1 Insights, Inc. | System and method for determining healthcare relationships |
| US20210005324A1 (en) * | 2018-08-08 | 2021-01-07 | Hc1.Com Inc. | Methods and systems for a health monitoring command center and workforce advisor |
| US20180045744A1 (en) * | 2015-01-16 | 2018-02-15 | Ameritox, Llc | Normalizing measured drug concentrations in oral fluids and testing for potential non-compliance with drug treatment regimen |
| CA2988724C (en) * | 2015-04-09 | 2023-10-10 | Diane R. Mould | Systems and methods for patient-specific dosing |
| NZ747648A (en) | 2016-04-15 | 2025-05-30 | Takeda Pharmaceuticals Co | Method and apparatus for providing a pharmacokinetic drug dosing regimen |
| US10896749B2 (en) * | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
| CN109718112B (zh) * | 2017-10-30 | 2020-12-29 | 京东方科技集团股份有限公司 | 用药提醒方法、装置及计算机可读存储介质 |
| JP2021518603A (ja) * | 2018-03-20 | 2021-08-02 | シートムエックス セラピューティクス，インコーポレイテッド | 哺乳動物対象における活性化可能抗体種の定量薬理学モデリングのためのシステムおよび方法 |
| CN108334116A (zh) * | 2018-04-23 | 2018-07-27 | 上海健康医学院 | 一种动态可控的微剂量药液精准输送系统及方法 |
| EA202092953A1 (ru) * | 2018-06-06 | 2021-04-12 | Минорикс Терапьютикс С.Л. | Способ введения терапевтически эффективного количества 5-[[4-[2-[5-(1-гидроксиэтил)пиридин-2-ил]этокси]фенил]метил]-1,3-тиазолидин-2,4-диона |
| KR20210078531A (ko) * | 2018-10-23 | 2021-06-28 | 암젠 인크 | 실시간 예측을 위한 라만 분광 모델의 자동 교정 및 자동 유지 관리 |
| WO2020132691A1 (en) * | 2018-12-21 | 2020-06-25 | Thsee, Llc | Method for optimization of cannabis dosage and mixture of active cannabinoids |
| WO2021097653A1 (en) * | 2019-11-19 | 2021-05-27 | National University Of Singapore | Optimisation of combination drug therapies |
| US20210304846A1 (en) * | 2020-03-29 | 2021-09-30 | Stephen J. Brown | Personalized compounding of therapeutic components and tracking of their influence on a measured parameter using a complex interaction model |
| CN111489822A (zh) * | 2020-04-02 | 2020-08-04 | 首都医科大学附属北京安定医院 | 一种治疗药物监测结果解释系统 |
| CN111870770A (zh) * | 2020-08-31 | 2020-11-03 | 上海应用技术大学 | 一种智能远程输液泵控制监测系统 |
| KR102481888B1 (ko) | 2020-09-01 | 2022-12-28 | 고려대학교 산학협력단 | 딥러닝을 이용한 수면유도제 투여량 예측방법 및 예측 장치 |
| CN113823365A (zh) * | 2021-09-30 | 2021-12-21 | 北京兴德通医药科技股份有限公司 | 临床研究质量控制方法、系统、电子设备和存储介质 |
| KR102840320B1 (ko) | 2023-02-13 | 2025-08-01 | 주식회사 지오비전 | 공동 다층 퍼셉트론 모델을 이용한 약제 농도 모니터링 시스템 |
| WO2025006459A1 (en) * | 2023-06-29 | 2025-01-02 | Prxcision, Inc. | Machine learning for real-time decision support |
| KR20250028730A (ko) * | 2023-08-22 | 2025-03-04 | 충북대학교 산학협력단 | 혈중 농도 변화 모사를 위한 약물 평가 방법 및 약물 평가 시스템 |
| WO2025059764A1 (en) * | 2023-09-18 | 2025-03-27 | Appmed Inc. | System and method for monitoring and identifying posology efficacy for an individual |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1367701A (zh) * | 1999-05-11 | 2002-09-04 | 奥索－麦克尼尔药物公司 | 红细胞生成素给药的药代动力学和药效模型 |
| US7124031B1 (en) * | 2000-05-11 | 2006-10-17 | Medco Health Solutions, Inc. | System for monitoring regulation of pharmaceuticals from data structure of medical and labortory records |
| US6599281B1 (en) * | 2000-05-03 | 2003-07-29 | Aspect Medical Systems, Inc. | System and method for adaptive drug delivery |
| US7860583B2 (en) * | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
| US20040014097A1 (en) * | 2002-05-06 | 2004-01-22 | Mcglennen Ronald C. | Genetic test apparatus and method |
| US7585680B2 (en) * | 2003-08-28 | 2009-09-08 | Marshfield Medical Research And Education Foundation | Method and device for monitoring medication usage |
| GB0420256D0 (en) * | 2004-09-13 | 2004-10-13 | Cassells John M | Method and apparatus for sampling and analysis of fluids |
| KR101637140B1 (ko) * | 2005-05-09 | 2016-07-06 | 테라노스, 인코포레이티드 | 현장진료 유체 시스템 및 그 용도 |
| US20060283465A1 (en) * | 2005-06-16 | 2006-12-21 | Nickel Janice H | Smart drug delivery system and a method of implementation thereof |
| EP2508621B1 (en) * | 2005-11-29 | 2014-11-05 | Children's Hospital Medical Center | Optimization and individualization of medication selection and dosing |
| KR100867324B1 (ko) * | 2007-03-13 | 2008-11-06 | 가톨릭대학교 산학협력단 | 혈중약물농도측정 처방 자동화 방법 |
| US20080262873A1 (en) * | 2007-04-18 | 2008-10-23 | Janus Health, Inc. | Patient management system and method |
| CN100580448C (zh) * | 2007-08-10 | 2010-01-13 | 复旦大学附属华山医院 | 一种测定人血浆中苯妥英及其前体药物和代谢物的方法 |
| CN103323610B (zh) | 2007-10-02 | 2016-12-28 | 赛拉诺斯股份有限公司 | 模块化现场护理装置及其应用 |
| US20110184379A1 (en) * | 2008-03-27 | 2011-07-28 | Medtronic, Inc. | Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools |
| CN102395310A (zh) * | 2009-02-26 | 2012-03-28 | 莫尔研究应用有限公司 | 用于自动监控糖尿病相关治疗的方法以及系统 |
| CN102472758B (zh) * | 2009-07-22 | 2015-05-06 | 伊莱利利公司 | 预测与药物治疗相关的重量增加的方法 |
| US20120203573A1 (en) * | 2010-09-22 | 2012-08-09 | I.D. Therapeutics Llc | Methods, systems, and apparatus for optimizing effects of treatment with medication using medication compliance patterns |
-
2013
- 2013-10-21 US US14/059,173 patent/US20140114676A1/en not_active Abandoned
- 2013-10-22 WO PCT/US2013/066238 patent/WO2014066428A1/en active Application Filing
- 2013-10-22 KR KR1020157011292A patent/KR20150079660A/ko not_active Withdrawn
- 2013-10-22 AU AU2013334700A patent/AU2013334700A1/en not_active Abandoned
- 2013-10-22 CN CN201380067536.9A patent/CN104884029A/zh active Pending
- 2013-10-22 EP EP13848501.6A patent/EP2911642B1/en active Active
- 2013-10-22 HK HK16102367.3A patent/HK1214498A1/zh unknown
- 2013-10-22 CA CA2887669A patent/CA2887669A1/en active Pending
- 2013-10-22 IN IN3826DEN2015 patent/IN2015DN03826A/en unknown
-
2016
- 2016-05-19 US US15/159,568 patent/US20160342768A1/en not_active Abandoned
-
2018
- 2018-06-08 AU AU2018204120A patent/AU2018204120A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2911642B1 (en) | 2022-11-16 |
| CA2887669A1 (en) | 2014-05-01 |
| AU2013334700A1 (en) | 2015-04-30 |
| US20140114676A1 (en) | 2014-04-24 |
| AU2018204120A1 (en) | 2018-06-28 |
| EP2911642A1 (en) | 2015-09-02 |
| EP2911642A4 (en) | 2016-06-08 |
| HK1214498A1 (zh) | 2016-07-29 |
| WO2014066428A1 (en) | 2014-05-01 |
| US20160342768A1 (en) | 2016-11-24 |
| KR20150079660A (ko) | 2015-07-08 |
| CN104884029A (zh) | 2015-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN03826A (enrdf_load_stackoverflow) | ||
| MX2021011813A (es) | Sistemas y metodos para compensar a largo plazo la sensibilidad de la deriva de sensores electroquimicos de gas expuestos a oxido nitrico. | |
| EP2911717A4 (en) | DEVICE, SYSTEM AND METHOD FOR TRACKING THE DELIVERY OF A MEDICAMENT | |
| SG10201902353UA (en) | Capturing specific nucleic acid materials from individual biological cells in a micro-fluidic device | |
| MX2023000359A (es) | Provision de un regimen de dosificacion de farmaco farmacocinetico. | |
| BR112012020270A2 (pt) | sistema e método para administrar medicamentos com base em valores de urina. | |
| EP2521587A4 (en) | RELEASE SYSTEM | |
| EP2968732A4 (en) | LIQUID DISPENSING SYSTEM AND METHOD FOR LIQUID DISTRIBUTION TO A PATIENT | |
| MX2019006900A (es) | Metodos de monitoreo terapeutico de farmacos depuradores de nitrogeno. | |
| MX2020001369A (es) | Sistema de analisis para el cuidado de un paciente. | |
| MX2016008138A (es) | Sistema para el suministro transdermico de ingredientes activos. | |
| BR112014010139A2 (pt) | formulação farmacêutica, método de redução do nível de açúcar no sangue de um paciente e polipeptídeo | |
| MX373138B (es) | Inhalador de polvo seco y método de uso. | |
| EA201400737A1 (ru) | Система доставки на основе множества пеллет с немедленным высвобождением активного вещества | |
| EA201590797A1 (ru) | Препараты с модифицированным высвобождением опрозомиба | |
| NZ702342A (en) | Pharmaceutical formulation | |
| PH12015502556A1 (en) | Modified release formulation | |
| NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
| MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
| ATE499040T1 (de) | Vorrichtung zur arzneimittelverabreichung und/oder überwachung des zustandes eines patienten | |
| EA201391023A1 (ru) | Способ снижения боли у животных семейства собачьих с помощью трансдермального раствора фентанила | |
| BR112017022984A2 (pt) | dispositivo para facilitar o posicionamento de um cateter para administrar um medicamento em um paciente que esteja respirando espontaneamente | |
| WO2013188437A3 (en) | Ex vivo methods to identify circulating drug metabolites with drug interaction potential | |
| MX2011011879A (es) | Uso de las betaxantinas y sus derivados para preparar un medicamento para el tratamiento de la prediabetes y diabetes. | |
| 田村典朗 | Post-approval appending of CSARs to drug package inserts: an analysis of the types of adverse reactions and time to addition |